Adjusted ORs for the risk of PH.

<p>OR, odds ratio; PH, peripartum hysterectomy.</p>a<p>ORs were adjusted for all variables in the table.</p

The numbers and rates^a of PHs and UAEs and the <i>P</i>-values for these rates during the study period.

<p>PH, peripartum hysterectomy; UAE, uterine artery embolization.</p><p>The <i>P</i>-value was evaluated by logistic regression analysis.</p>a<p>Rate was calculated per 1000 deliveries.</p

The numbers and rates^a of risk factors for PH and UAE and their trends (<i>P</i>-values) during the study period.

<p>PH, peripartum hysterectomy; UAE, uterine artery embolization.</p><p>The <i>P</i>-value was evaluated by logistic regression analysis.</p>a<p>Rates were calculated per 1,000 deliveries.</p

The numbers and rates^a of UAE according to each risk factor and their trends during the study period.

<p>UAE, uterine artery embolization.</p><p><i>p</i>-values were evaluated by multivariate logistic regression analysis.</p>a<p>Rates were calculated per 1,000 deliveries with each risk factor.</p

Adjusted ORs for the risk of UAE.

<p>OR, odds ratio; UAE, uterine artery embolization.</p>a<p>ORs were adjusted for all variables in the table.</p

The trend for GDM prevalence by age group.

<p>The trend for GDM prevalence by age group.</p

The adjusted ORs for the risk of GDM.

<p>^aORs were adjusted for all variables in the table.</p><p>The adjusted ORs for the risk of GDM.</p

Secular trends of risk factors for GDM among women of child-bearing age from 2007 to 2010.

<p>Data are mean±standard errors or %±standard errors. BMI, body mass index; WC, waist circumference; HTN, hypertension; HDL-C, high-density lipoprotein cholesterol; TG, triglyceride; DM, diabetes mellitus.</p><p>*Obesity was defined as BMI ≥25 kg/m².</p><p>†Obesity was defined as WC≥85cm.</p><p>Secular trends of risk factors for GDM among women of child-bearing age from 2007 to 2010.</p

The basic characteristics of the study population (2007–2010).

<p>Data are mean±standard deviation or %.</p><p>The basic characteristics of the study population (2007–2010).</p

The trend for GDM prevalence (▲) and GDM with insulin treatment among all GDM (◆).

<p>The trend for GDM prevalence (▲) and GDM with insulin treatment among all GDM (◆).</p